Macquarie Group Limited vs Takeda Pharmaceutical Company Limited
Market cap comparison over time
Macquarie Group Limited
$60.0B
Rank #233
Takeda Pharmaceutical Company Limited
$63.9B
Rank #229
Market Cap Over Time
Key Moments
- Macquarie Group Limited overtook Takeda Pharmaceutical Company Limited by 2021
- Takeda Pharmaceutical Company Limited overtook Macquarie Group Limited by 2022
- Macquarie Group Limited overtook Takeda Pharmaceutical Company Limited by 2023
- Takeda Pharmaceutical Company Limited overtook Macquarie Group Limited by 2025
Year-by-Year Comparison
| Year | Macquarie Group Limited | Takeda Pharmaceutical Company Limited | Leader |
|---|---|---|---|
| 2026 | $60.0B | $63.9B | Takeda Pharmaceutical Company Limited |
| 2025 | $49.5B | $50.3B | Takeda Pharmaceutical Company Limited |
| 2024 | $52.2B | $41.6B | Macquarie Group Limited |
| 2023 | $41.9B | $38.6B | Macquarie Group Limited |
| 2022 | $36.6B | $37.6B | Takeda Pharmaceutical Company Limited |
| 2021 | $43.4B | $27.3B | Macquarie Group Limited |
| 2020 | $28.2B | $31.2B | Takeda Pharmaceutical Company Limited |
| 2019 | $27.4B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2018 | $20.6B | $28.0B | Takeda Pharmaceutical Company Limited |
| 2017 | $18.0B | $46.8B | Takeda Pharmaceutical Company Limited |
| 2016 | $14.9B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $13.4B | $41.4B | Takeda Pharmaceutical Company Limited |
| 2014 | $9.0B | $33.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $8.1B | $30.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $4.9B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2011 | $3.1B | $19.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $4.6B | $22.3B | Takeda Pharmaceutical Company Limited |
| 2009 | $5.7B | $20.5B | Takeda Pharmaceutical Company Limited |
| 2008 | $3.3B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2007 | $7.7B | $32.5B | Takeda Pharmaceutical Company Limited |
| 2006 | $7.8B | $39.6B | Takeda Pharmaceutical Company Limited |
| 2005 | $6.5B | $30.4B | Takeda Pharmaceutical Company Limited |
| 2004 | $4.2B | $24.2B | Takeda Pharmaceutical Company Limited |
| 2003 | $3.1B | $19.6B | Takeda Pharmaceutical Company Limited |
| 2002 | $2.0B | $22.5B | Takeda Pharmaceutical Company Limited |
| 2001 | $3.1B | $26.6B | Takeda Pharmaceutical Company Limited |
| 2000 | $2.3B | $30.0B | Takeda Pharmaceutical Company Limited |